Arkolith/Insider Trading/PTIX/Form 4

Arrow Alexander K.

Chief Financial OfficerProtagenic Therapeutics, Inc. ew (PTIX) · full profile →Form 4 · filed May 3, 2021
Net Buying
Open-Market Buys
$5K
Open-Market Sells
$0
Net Open-Market Flow
$5K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 30, 2021Buy(P)1K$2.29$2K120K
Apr 29, 2021Buy(P)1K$2.29$2K119K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-21-010335) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML